Li Lei, Guan Lihua, Tang Yueming, Zou Yutong, Zhong Jian, Qiu Ling
Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, People's Republic of China.
State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, People's Republic of China.
Clin Exp Med. 2023 Nov;23(7):3969-3980. doi: 10.1007/s10238-023-01049-6. Epub 2023 Apr 27.
Over the past two decades, there has been a significant growth in articles focusing on the genetics of pheochromocytoma and paraganglioma (PPGL). We used bibliometric methods to investigate the historical changes and trend in PPGL research. There was a total of 1263 articles published in English from 2002 to 2022 included in our study. The number of annual publications and citations in this field has been increasing in the past 20 years. Furthermore, most of the publications originated from the European countries and the United States. The co-occurrence analysis showed close cooperation between different countries, institutions, or authors. The dual-map discipline analysis revealed that majority articles focused on four disciplines: #2 (Medicine, Medical, Clinical), #4 (Molecular, Biology, Immunology), #5 (Health, Nursing, Medicine), and #8 (Molecular, Biology, Genetics). The hotspot analysis revealed the keywords that have been landmark for PPGL genetics research in different time periods, and there was continued interest in gene mutations, especially on SDHX family genes. In conclusion, this study displays the current status of research and future trends in the genetics of PPGL. In future, more in-depth research should concentrate on crucial mutation genes and their specific mechanisms to assist in molecular target therapy. It is hoped that this study may help to provide directions for future research on genes and PPGL.
Endocrinol Metab (Seoul). 2020-12
J Mol Endocrinol. 2023-4-1
Best Pract Res Clin Endocrinol Metab. 2020-3-10
Biochim Biophys Acta Rev Cancer. 2024-9
J Clin Endocrinol Metab. 2016-3
Genet Med. 2018-7-16
Presse Med. 2018
J Alzheimers Dis Rep. 2024-1-29
Curr Treat Options Oncol. 2020-8-29
Best Pract Res Clin Endocrinol Metab. 2020-3-10
Clin Cancer Res. 2020-7-15
Best Pract Res Clin Endocrinol Metab. 2019-10-24
Curr Cardiol Rep. 2019-7-31
Genet Med. 2018-5-8